| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |